Final Dataset of Phase 2 ENTRIGUE Trial of Pegozafermin
Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s...
5303 articles
Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s...
Comilla Sasson, MD, PhD, Vice President for Healthcare Business Solutions at the American Heart Association and a practicing Emergency Medicine physicia...
Erin Crane, MD, MPH, gynecologic oncologist with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalenc...
Claude Royster, VP and GM of Healthcare Select Specialties, Health & Wellness at Synchrony discusses recent research revealing that more than one-third ...
Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine ...
Mary Beth Cicero, CEO and co-founder of 3Daughters discusses the development of the company's lead product candidate, a frameless self-assembling int...
Colleen Acosta, CEO and Co-Founder of Freya Biosciences, a biotech company dedicated to advancing women's reproductive health discusses the critical nee...
Lee, MD, Cherng Family Director's Chair, Center for Integrative Oncology at City of Hope, one of the largest cancer research and treatment organizations...
John Laird, MD, Chief Medical Officer for Peripheral Vascular Health at Medtronic, and Terry Litchfield, President of Access Solutions and a patient adv...
Timothy Hand, Ph.D., Associate Professor at the University of Pittsburgh Medical Center, Mellon Institute, Children's Hospital of Pittsburgh discusses n...